Texas Chapter of AACE (TX-AACE) Annual Meeting / Texas Endocrine Surgical Society (TESS) Surgical Symposium

San Antonio , TX US
August 4, 2017 to August 5, 2017

Target Audience

Endocrinologists, endocrine surgeons, and other health care professionals living in Texas who practice, or are interested in, the treatment of endocrine disease states.

Learning Objectives

  1. After participating in a pre-meeting assessment tool, attendees will be able to recognize areas of potential shortcoming and strive to improve knowledge and consequential healthcare practices
  2. Understand the cardiovascular effects from GLP1 & SGLT2 trials
  3. Risk and benefits of these new cardiovascular agents in diabetes
  4. Understand yearly event rate in diabetes of new trials
  5. Define type 2 diabetes remission
  6. Analyze the evidence base in support of remission of type 2 diabetes and understand a systematic approach to studying it
  7. Differentiate diabetes remission and prevention
  8. Increase awareness on the role of insulin resistance, diabetes and ethnicity to the development of non-alcoholic fatty liver disease
  9. Understand dilemmas that the endocrinologist faces in the diagnosis and management of such patients
  10. Review the choices and expected benefits of current treatments for non-alcoholic fatty liver disease
  11. Define the orderly workup and differential diagnosis for fasting hypoglycemia
  12. Identify the clinical and pathologic features of adult nesidioblastosis
  13. Identify indications for work up of hypoglycemia
  14. Recognize obscure causes of hypoglycemia in a diabetic patient
  15. Recognize the essential elements of the diagnostic workup to establish the presence of surgically correctable (endogenous) hyperinsulinism
  16. Understand the current role of preoperative imaging tests for patients with insulinoma
  17. Describe the current surgical approach and strategy for resection of solitary insulinoma, noninsulinoma pancreatogenous hypoglycemia, and adult nesidioblastosis
  18. Allow the audience to further explore and clarify issues related to the morning's presentations with the faculty
  19. Describe the investigations and differential diagnosis of hyperaldosteronism
  20. Interpret the results of adrenal vein sampling in patients with hyperaldosteronism
  21. Describe the medical and surgical management of hyperaldosteronism
  22. Discuss the optimal surgical approaches for management of patients with adrenal cortical carcinoma
  23. Summarize the potential indications for adjuvant and neoadjuvant systemic treatment of adrenal cortical carcinoma
  24. Describe current and potential future systemic treatment options for patients with advanced adrenal cortical carcinoma
  25. Recognize the prevalence of persistent and recurrent disease following surgical remission of Cushing’s disease and acromegaly
  26. Debate the patient specific characteristics which could be appropriate for treatment with mifepristone or pasireotide
  27. Discuss indications for mifepristone, pasireotide, in the treatment of Cushing’s syndrome and acromegaly
  28. At the conclusion of the meeting, attendees will be able to measure learning that occurred that will enable the use of new healthcare techniques and practices and to review or confirm existing care modalities.
  29. After participating in a pre-meeting assessment tool, attendees will be able to recognize areas of potential shortcoming and strive to improve knowledge and consequential healthcare practices.
  30. Describe a central node dissection and differentiate a therapeutic and prophylactic central neck dissection
  31. Define the role of central node dissection in the management of papillary thyroid cancer
  32. Review the controversy surrounding prophylactic central node dissection in patients with clinically node negative disease
  33. Describe the genotype-phenotype relationships of various RET protooncogene mutations in children with MEN2
  34. Understand the basis for current recommendations of timing of early thyroidectomy based on mutation risk stratification
  35. Understand the current controversies regarding extent of cervical lymphadenectomy and management of the parathyroid glands in children undergoing early thyroidectomy for MEN2
  36. Identify causes of enlarged extraocular muscles that can mimic Graves ophthalmopathy
  37. Explain the role of corticosteroids in the treatment of Graves ophthalmopathy
  38. Summarize the individualized approach to medical and surgical treatment of Graves ophthalmopathy to optimize results
  39. Review the anatomy of the recurrent laryngeal nerve and its association with the ligament of berry and tubercle of zuckerkandl, injury rates and implications
  40. Discuss management of the tubercle of zuckerkandl during thyroid surgery
  41. Implications of inadequate management of the tubercle of zuckerkandl/ligament of berry for the endocrinologist
  42. Allow the audience to further explore and clarify issues related to the morning's presentations with the faculty
  43. Determine which patients with low bone density require treatment, along with optimal duration of treatment
  44. Select antiresorptive agents based on the patient's individual characteristics and preferences
  45. Recognize the benefits of anabolic agents in specific subpopulations of osteoporosis patients
  46. 4D-CT evaluation of hyperparathyroidism
  47. Ultrasound characteristics of parathyroid adenomas vs. lymph nodes
  48. Intraoperative support for minimally invasive parathyroidectomy and localization of transplanted parathyroid tissue
  49. Understand the etiologies of hypoparathyroidism
  50. Discuss the medical treatment of hypoparathyroidism
  51. Understand the use of parathyroid hormone in hypoparathyroidism
  52. Through fellow presentations, allow the audience to learn and participate in the evaluation of usual medical cases.
  53. At the conclusion of the meeting, attendees will be able to measure learning that occurred that will enable the use of new healthcare techniques and practices and to review or confirm existing care modalities.                                                                               
Additional information
Available for MOC Points?: 
No
Practice Area: 
Diabetes
Hypoglycemia
Obesity
General Endo
Course summary
Available credit: 
  • 12.75 AMA
  • 12.75 Attendance
Course opens: 
08/04/2017
Course expires: 
08/05/2018
Event starts: 
08/04/2017 - 8:00am
Event ends: 
08/05/2017 - 5:30pm
Cost:
$0.00

Friday, August 4, 2017

7:00 - 8:00 AMContinental Breakfast
8:00 - 8:30 AMWelcoming Remarks & Pre Meeting Assessment 
Objectives:
  1. After participating in a pre-meeting assessment tool, attendees will be able to recognize areas of potential shortcoming and strive to improve knowledge and consequential healthcare practices

SESSION 1 -

DIABETES | METABOLIC SECTION

8:30 - 9:05 AMA Cardiovascular Diagnosis & GLP1/SGLT2 
Robert Chilton, DO, FACC 
Objectives:
  1. Understand the cardiovascular effects from GLP1 & SGLT2 trials
  2. Risk and benefits of these new cardiovascular agents in diabetes
  3. Understand yearly event rate in diabetes of new trials
9:05 - 9:40 AMSystematically Assessing the Promise of Diabetes Remission 
Hertzel C. Gerstein, MD, MSc, FRCPC 
Objectives:
  1. Define type 2 diabetes remission
  2. Analyze the evidence base in support of remission of type 2 diabetes and understand a systematic approach to studying it
  3. Differentiate diabetes remission and prevention
9:40 - 10:15 AMMetabolic Insights into Non-Alcoholic Fatty Liver Disease: The overlooked complication of type 2 diabetes 
Kenneth Cusi, MD, FACP, FACE 
Objectives:
  1. Increase awareness on the role of insulin resistance, diabetes and ethnicity to the development of non-alcoholic fatty liver disease
  2. Understand dilemmas that the endocrinologist faces in the diagnosis and management of such patients
  3. Review the choices and expected benefits of current treatments for non-alcoholic fatty liver disease
10:15 - 10:45 AMBreak
10:45 - 11:20 AMInteresting Cases
Fasting Hypoglycemia in a Previously Healthy Nurse 

Henry Reinhart, MD 
Objectives:
  1. Define the orderly workup and differential diagnosis for fasting hypoglycemia
  2. Identify the clinical and pathologic features of adult nesidioblastosis
 An Unusual Cause of Hypoglycemia 
Stacey Milan, MD, FACS 
Objectives:
  1. Identify indications for work up of hypoglycemia
  2. Recognize obscure causes of hypoglycemia in a diabetic patient
11:20 - 11:55 AMSurgical Management of Endogenous Hyperinsulinism 
Terry C. Lairmore, MD, FACS 
Objectives:
  1. Recognize the essential elements of the diagnostic workup to establish the presence of surgically correctable (endogenous) hyperinsulinism
  2. Understand the current role of preoperative imaging tests for patients with insulinoma
  3. Describe the current surgical approach and strategy for resection of solitary insulinoma, noninsulinoma pancreatogenous hypoglycemia, and adult nesidioblastosis
11:55 - 12:15 PMDiabetes / Metabolic Panel Discussion 
Robert Chilton, DO, FACC; Hertzel C. Gerstein, MD, MSc, FRCPC; Kenneth Cusi, MD, FACP, FACE; Terry C. Lairmore, MD, FACS 
Objectives:
  1. Allow the audience to further explore and clarify issues related to the morning's presentations with the faculty
12:30 - 2:00 PMLunch

SESSION 2 -

ADRENAL | PITUITARY | NEUROENDOCRINE SECTION

2:00 - 2:35 PMControversies in the Management of Primary Hyperaldosteronism 
Alan Dackiw, MD, PhD, MBA, FACS 
Objectives:
  1. Describe the investigations and differential diagnosis of hyperaldosteronism
  2. Interpret the results of adrenal vein sampling in patients with hyperaldosteronism
  3. Describe the medical and surgical management of hyperaldosteronism
2:35 - 3:05 PMCurrent Management of Adrenal Cortical Carcinoma 
Jeffrey E. Lee, MD 
Objectives:
  1. Discuss the optimal surgical approaches for management of patients with adrenal cortical carcinoma
  2. Summarize the potential indications for adjuvant and neoadjuvant systemic treatment of adrenal cortical carcinoma
  3. Describe current and potential future systemic treatment options for patients with advanced adrenal cortical carcinoma
3:05 - 3:40 PMBreak
3:40 - 4:15 PMChallenging Pituitary Cases 
Thomas Blevins, MD, FNLA, FACE, ECNU; 
Sue Samson, MD, PhD, FRCPC, FACE 

Objectives:
  1. Recognize the prevalence of persistent and recurrent disease following surgical remission of Cushing’s disease and acromegaly
  2. Debate the patient specific characteristics which could be appropriate for treatment with mifepristone or pasireotide
  3. Discuss indications for mifepristone, pasireotide, in the treatment of Cushing’s syndrome and acromegaly
4:15 - 4:45 PMPost Meeting Assessment 
Objectives:
  1. At the conclusion of the meeting, attendees will be able to measure learning that occurred that will enable the use of new healthcare techniques and practices and to review or confirm existing care modalities.
4:45 - 5:30 PMTX-AACE Chapter Business Meeting / Reception

Saturday, August 5, 2017

6:45 - 7:40 AMContinental Breakfast
7:40 - 8:05 AMWelcoming Remarks & Pre Meeting Assessment 
Objectives:
  1. After participating in a pre-meeting assessment tool, attendees will be able to recognize areas of potential shortcoming and strive to improve knowledge and consequential healthcare practices.

SESSION 3 –

THYROID SECTION

8:05 - 9:05 AMPros / Cons Central Lymph Node Dissection 
There is no role for Prophylactic Central Compartment Neck Dissection 

Christopher McHenry, MD
 Routine Central Lymph Node Dissection Should be Performed in Patients with Papillary Thyroid Cancer 
Samuel Snyder, MD, FACS 
Objectives:
  1. Describe a central node dissection and differentiate a therapeutic and prophylactic central neck dissection
  2. Define the role of central node dissection in the management of papillary thyroid cancer
  3. Review the controversy surrounding prophylactic central node dissection in patients with clinically node negative disease

Meets CME requirements for ECNU recertification
9:05 - 9:40 AMTiming of Early Preventative Thyroidectomy in Children with MEN 2 
Terry C. Lairmore, MD, FACS
Objectives:
  1. Describe the genotype-phenotype relationships of various RET protooncogene mutations in children with MEN2
  2. Understand the basis for current recommendations of timing of early thyroidectomy based on mutation risk stratification
  3. Understand the current controversies regarding extent of cervical lymphadenectomy and management of the parathyroid glands in children undergoing early thyroidectomy for MEN2
9:40 - 10:10 AMBreak
10:10 - 10:45 AMGraves Ophthalmopathy: Advances in diagnosis and treatment 
Constance Fry, MD 
Objectives:
  1. Identify causes of enlarged extraocular muscles that can mimic Graves ophthalmopathy
  2. Explain the role of corticosteroids in the treatment of Graves ophthalmopathy
  3. Summarize the individualized approach to medical and surgical treatment of Graves ophthalmopathy to optimize results
10:45 - 11:20 AMManagement of the Recurrent Laryngeal Nerve at the Ligament of Berry: Implications for the endocrinologist and surgeon 
Nathan Hales, MD, FACS 
Objectives:
  1. Review the anatomy of the recurrent laryngeal nerve and its association with the ligament of berry and tubercle of zuckerkandl, injury rates and implications
  2. Discuss management of the tubercle of zuckerkandl during thyroid surgery
  3. Implications of inadequate management of the tubercle of zuckerkandl/ligament of berry for the endocrinologist
11:20 - 11:55 AMThyroid Panel Discussion 
Christopher McHenry, MD; Samuel Snyder, MD, FACS;
Terry C. Lairmore, MD, FACS; Constance Fry, MD; Nathan Hales, MD, FACS 

Objectives:
  1. Allow the audience to further explore and clarify issues related to the morning's presentations with the faculty
11:55 - 1:30 PMLunch

SESSION 4 –

BONE SECTION

1:30 - 2:15 PMOsteoporosis & Drug Classes – A Case-based Discussion 
Laila Tabatabai, MD 
Objectives:
  1. Determine which patients with low bone density require treatment, along with optimal duration of treatment
  2. Select antiresorptive agents based on the patient's individual characteristics and preferences
  3. Recognize the benefits of anabolic agents in specific subpopulations of osteoporosis patients
2:15 - 2:45 PMParathyroid Imaging: Current concepts 
Maria Gule-Monroe, MD 
Objectives:
  1. 4D-CT evaluation of hyperparathyroidism
  2. Ultrasound characteristics of parathyroid adenomas vs. lymph nodes
  3. Intraoperative support for minimally invasive parathyroidectomy and localization of transplanted parathyroid tissue
2:45 - 3:20 PMHypoparathyroidism - A Case-based Discussion 
Mimi Hu, MD 
Objectives:
  1. Understand the etiologies of hypoparathyroidism
  2. Discuss the medical treatment of hypoparathyroidism
  3. Understand the use of parathyroid hormone in hypoparathyroidism
3:20 - 3:55 PM 
3:20-3:35 
  
3:35-3:50 
  
3:50-3:55
Interesting Cases 
Real Pregnancy or Uncontrolled Hypothyroidism? 
Christie G. Turin, MD 

An Adult with a Very Low Alkaline Phosphatase 
Thomas Blevins, MD, FNLA, FACE, ECNU

Q & A 
Objectives:
  1. Through fellow presentations, allow the audience to learn and participate in the evaluation of usual medical cases.
3:55 - 4:30 PMPost Meeting Assessment / Adjourn 
Objectives:
  1. At the conclusion of the meeting, attendees will be able to measure learning that occurred that will enable the use of new healthcare techniques and practices and to review or confirm existing care modalities.
Grand Hyatt San Antonio
600 E Market St
San Antonio , TX 78205
United States

Thomas Blevins, MD, FNLA, FACE, ECNU

Texas Diabetes and Endocrinology, PA

Austin, TX

Robert J. Chilton, DO, FACC

Associate Professor

Department of Medicine, Division of Cardiology 

The University of Texas Health Science Center at San Antonio

San Antonio, TX

Kenneth Cusi, MD, FACP, FACE

Professor of Medicine

Chief, Division of Endocrinology, Diabetes and Metabolism

University of Florida

School of Medicine

Gainesville, FL

Alan Dackiw, MD, PhD, MBA, FACS

Professor of Surgery

University of Texas Southwestern Medical Center

Dallas, TX

Constance Fry, MD

Associate Professor of Ophthalmology

Chief of Ophthalmic Plastic Surgery & Ophthalmic Oncology

The University of Texas Health Science Center at San Antonio

San Antonio, TX

Hertzel Gerstein, MD, MSc, FRCPC

Professor of Medicine,

Director, Division of Endocrinology & Metabolism

Population Health Research Institute Chair in Diabetes

McMaster University

Hamilton, Ontario, Canada

Maria Gule-Monroe, MD

Assistant Professor -Diagnostic Radiology

Neuroradiology Section

The University of Texas

MD Anderson Cancer Center

Houston, TX

Nathan W. Hales, MD, FACS

Associate Professor

Uniformed Services University of the Health Sciences, Civilian

Otolaryngology, Head and Neck Surgical Oncology

Thyroid and Parathyroid Surgery

San Antonio Head and Neck

San Antonio, TX

Mimi Hu, MD

Associate Professor

Department of Endocrine Neoplasia and Hormonal Disorders

University of Texas M. D. Anderson Cancer Center

Houston, TX

Terry C. Lairmore, MD, FACS

Professor of Surgery

Director, Division of Surgical Oncology

Baylor Scott & White Health

Texas A&M University Health Science Center

Temple, TX

Jeffrey E. Lee, MD

Professor and Chair, Department of Surgical Oncology

Irving and Nadine Mansfield and Robert David Levitt Cancer Research Chair

The University of Texas MD Anderson Cancer Center

Houston, TX

Christopher R. McHenry

Vice Chairman Department of Surgery

MetroHealth Medical Center

Professor of Surgery

Case Western Reserve University School of Medicine

Cleveland, OH

Stacey Milan, MD, FACS

Assistant Professor of Surgery

Baylor Scott & White Hospital

Temple, TX

Henry A. Reinhart, MD

Assistant Professor of Surgery

University of Texas Rio Grande Valley School of Medicine

Edinburg, TX

Susan Samson, MD, PhD, FRCPC, FACE

Associate Professor of Medicine

Baylor College of Medicine

Medical Director, The Pituitary Center at Baylor St. Luke's Medical Center

Endocrinology Fellowship Director

Houston, TX

Samuel K. Snyder, MD, FACS

Vice-Chairman, Department of Surgery
Chief, Section of Endocrine Surgery

Baylor Scott & White Health

Texas A&M University Health Science Center

Temple, TX

Laila S. Tabatabai, MD

Assistant Professor of Clinical Medicine, Weill Cornell Medical College

Adjunct Assistant Professor of Internal Medicine, Texas A&M University, College of Medicine

Division of Endocrinology, Diabetes & Metabolism

Houston Methodist Hospital

Houston, TX

Christie G. Turin More, MD

Internal Medicine Resident

Baylor College of Medicine

Houston, TX

The American Association of Clinical Endocrinologists (AACE) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American Association of Clinical Endocrinologists (AACE) designates this live activity for a maximum of 12.75 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 12.75 AMA
  • 12.75 Attendance

Accreditation Period

Course opens: 
08/04/2017
Course expires: 
08/05/2018

Price

Cost:
$0.00
Please login or register to take this course.